|
Name |
3-Methyl-3-buten-1-OL
|
Molecular Formula | C5H10O | |
IUPAC Name* |
3-methylbut-3-en-1-ol
|
|
SMILES |
CC(=C)CCO
|
|
InChI |
InChI=1S/C5H10O/c1-5(2)3-4-6/h6H,1,3-4H2,2H3
|
|
InChIKey |
CPJRRXSHAYUTGL-UHFFFAOYSA-N
|
|
Synonyms |
3-METHYL-3-BUTEN-1-OL; 3-Methylbut-3-en-1-ol; 763-32-6; Isoprenol; 3-Buten-1-ol, 3-methyl-; Isobutenylcarbinol; Methallylcarbinol; 3-Isopentenyl alcohol; 2-Methyl-1-buten-4-ol; Isopropenylethyl alcohol; 3-methyl-3-butenol; Methallyl carbinol; KJ25C8CPFA; Methyl-3-but-3-en-1-ol; 2-methyl-4-hydroxy-1-butene; NSC-122673; EINECS 212-110-8; UNII-KJ25C8CPFA; NSC 122673; 3-methyl-but-3-en-1-ol; 3-methyl-3-butene-1-ol; EC 212-110-8; 3-methyl-3-butenyl alcohol; DSSTox_CID_31079; DSSTox_GSID_52506; Delta(3)-isopentenyl alcohol; 2-methyl-4-hydroxybut-1-ene; 3-METHYLENEBUTAN-1-OL; 3-Methyl-3-buten-1-ol purum; CHEMBL3561140; DTXSID4052506; CHEBI:62898; 3-Methyl-3-buten-1-ol, 97%; ZINC1712065; Tox21_303733; BBL027415; LMFA05000107; MFCD00002933; NSC122673; STL146351; 3-Methyl-3-buten-1-ol, >=97%; 4-HYDROXY-2-METHYL-1-BUTENE; AKOS005721136; SB83771; NCGC00357042-01; CAS-763-32-6; CS-0204343; FT-0616079; M0726; EN300-94630; A838675; Q408094; 3-Methyl-3-buten-1-ol, purum, >=98.0% (GC)
|
|
CAS | 763-32-6 | |
PubChem CID | 12988 | |
ChEMBL ID | CHEMBL3561140 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 86.13 | ALogp: | 1.3 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 6 | QED Weighted: | 0.503 |
Caco-2 Permeability: | -4.225 | MDCK Permeability: | 0.00003660 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.887 |
30% Bioavailability (F30%): | 0.923 |
Blood-Brain-Barrier Penetration (BBB): | 0.948 | Plasma Protein Binding (PPB): | 30.44% |
Volume Distribution (VD): | 1.188 | Fu: | 81.19% |
CYP1A2-inhibitor: | 0.174 | CYP1A2-substrate: | 0.399 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.665 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.285 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.295 |
CYP3A4-inhibitor: | 0.006 | CYP3A4-substrate: | 0.234 |
Clearance (CL): | 8.806 | Half-life (T1/2): | 0.835 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.042 |
Drug-inuced Liver Injury (DILI): | 0.032 | AMES Toxicity: | 0.019 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.028 |
Skin Sensitization: | 0.151 | Carcinogencity: | 0.779 |
Eye Corrosion: | 0.976 | Eye Irritation: | 0.995 |
Respiratory Toxicity: | 0.032 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001037 | 0.385 | D0EP8X | 0.269 | ||||
ENC001231 | 0.370 | D00AMQ | 0.235 | ||||
ENC000677 | 0.364 | D0C1QZ | 0.231 | ||||
ENC005107 | 0.357 | D04CRL | 0.211 | ||||
ENC000377 | 0.320 | D09KDV | 0.200 | ||||
ENC000288 | 0.300 | D0R3QY | 0.188 | ||||
ENC001835 | 0.294 | D0R9BG | 0.182 | ||||
ENC000532 | 0.280 | D06VNK | 0.167 | ||||
ENC000017 | 0.273 | D0G4JI | 0.167 | ||||
ENC000686 | 0.273 | D0GC2M | 0.162 |